Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy

Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy

BackgroundMinimal change disease (MCD) has a high recurrence rate, but currently, no biomarker can predict its recurrence. To this end, this study aimed at identifying potential serum cytokines as valuable biomarkers for predicting the risk of MCD recurrence.Materials and methodsRaybiotech 440 cytok...

Full description

Bibliographic Details
Main Authors: Mengqiu Bai, Jian Zhang, Xinwan Su, Xi Yao, Heng Li, Jun Cheng, Jianhua Mao, Xiayu Li, Jianghua Chen, Weiqiang Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Medicine
Subjects:
minimal change disease
IL-12p40
biomarker
cytokines
glucocorticoids therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.922193/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.922193/full

Similar Items